Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them

The aim of this review is to analyze reasons for the high cost of recombinant human trypsin, technological and economic obstacles limiting trypsin production and implementation, as well as practical means to solve these problems.Materials and methods. The properties of human trypsin, the recombinant...

Full description

Saved in:
Bibliographic Details
Main Author: S. V. Ponomarenko
Format: Article
Language:Russian
Published: IRBIS LLC 2018-11-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/262
Tags: Add Tag
No Tags, Be the first to tag this record!